Cargando…

The new useful high-resolution computed tomography finding for diagnosing fibrotic hypersensitivity pneumonitis: “hexagonal pattern”: a single-center retrospective study

BACKGROUND: Centrilobular nodules, ground-glass opacity (GGO), mosaic attenuation, air trapping, and three-density pattern were reported as high-resolution computed tomography (HRCT) findings characteristic of fibrotic hypersensitivity pneumonitis (HP). However, it is often difficult to differentiat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okabayashi, Hiroko, Fukuda, Taiki, Iwasawa, Tae, Oda, Tsuneyuki, Kitamura, Hideya, Baba, Tomohisa, Takemura, Tamiko, Sakagami, Takuro, Ogura, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897846/ https://www.ncbi.nlm.nih.gov/pubmed/35246090 http://dx.doi.org/10.1186/s12890-022-01869-4

Ejemplares similares

Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
por: Okuda, Ryo, et al.
Publicado: (2022)

Patients with Terminal Interstitial Pneumonia Require Comparable or More Palliative Pharmacotherapy for Refractory Dyspnea than Patients with Terminal Lung Cancer
por: Okabayashi, Hiroko, et al.
Publicado: (2021)

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance
por: Okuda, Ryo, et al.
Publicado: (2023)

Evaluation of lymphocytic infiltration in the bronchial glands of Sjögren’s syndrome in transbronchial lung cryobiopsy
por: Okabayashi, Hiroko, et al.
Publicado: (2020)

COVID-19 Pneumonia Resembling an Acute Exacerbation of Interstitial Pneumonia
por: Kitayama, Takaaki, et al.
Publicado: (2020)

Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2019)

Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
por: Ikeda, Satoshi, et al.
Publicado: (2017)

Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration
por: Ikeda, Satoshi, et al.
Publicado: (2022)

Anti-Inflammatory and/or Anti-Fibrotic Treatment of MPO-ANCA-Positive Interstitial Lung Disease: A Short Review
por: Yamakawa, Hideaki, et al.
Publicado: (2022)

Clusters of comorbidities in fibrotic hypersensitivity pneumonitis
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
por: Chen, Xueying, et al.
Publicado: (2023)

Comparison of Clinical Characteristics and Outcomes between Idiopathic and Secondary Pleuroparenchymal Fibroelastosis
por: Oda, Tsuneyuki, et al.
Publicado: (2021)

Usefulness and safety of transbronchial lung cryobiopsy for reassessment of treatment in the clinical course of diffuse parenchymal lung disease
por: Sato, Yozo, et al.
Publicado: (2022)

Radiological and Pathological Features of Cyst Formation in Idiopathic Multicentric Castleman Disease
por: Otoshi, Ryota, et al.
Publicado: (2023)

A 16-year Follow-up Case of Interstitial Pneumonia with Systemic Sclerosis-rheumatoid Arthritis Overlap Syndrome
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

Interstitial Lung Disease with Anti-melanoma Differentiation-associated Protein 5 Antibody: Rapidly Progressive Perilobular Opacity
por: Chino, Haruka, et al.
Publicado: (2019)

Fibrotic Hypersensitivity Pneumonitis: Key Issues in Diagnosis and Management
por: Kouranos, Vasileios, et al.
Publicado: (2017)

Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis
por: Nishida, Takashi, et al.
Publicado: (2021)

Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes
por: Kang, Jieun, et al.
Publicado: (2021)

Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?
por: Pereira, João O., et al.
Publicado: (2023)

Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Features of transbronchial lung cryobiopsy‐diagnosed fibrotic hypersensitivity pneumonitis
por: Zhan, Xi, et al.
Publicado: (2022)

Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis
por: Oh, Ju Hyun, et al.
Publicado: (2023)

Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy
por: Sasano, Hajime, et al.
Publicado: (2016)

Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis
por: Yamakawa, Hideaki, et al.
Publicado: (2016)

Criteria for progressive fibrotic hypersensitivity pneumonitis in a Portuguese patient cohort
por: Seixas, E, et al.
Publicado: (2022)

High-resolution computed tomography features of asbestosis versus fibrotic hypersensitivity pneumonitis: an observational study
por: Ma, Ruimin, et al.
Publicado: (2022)

Prognostic Factors in Interstitial Lung Disease Associated with Primary Sjögren’s Syndrome: A Retrospective Analysis of 33 Pathologically–Proven Cases
por: Enomoto, Yasunori, et al.
Publicado: (2013)

Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis
por: Wang, Junyi, et al.
Publicado: (2022)

Dyskeratosis congenita with heterozygous RTEL1 mutations presenting with fibrotic hypersensitivity pneumonitis
por: Han, Jinhee, et al.
Publicado: (2023)

Desquamative Interstitial Pneumonia Complicated with IgG4-related Lung Disease
por: Yamakawa, Hideaki, et al.
Publicado: (2017)

Disruption in the balance between apolipoprotein A‐I and mast cell chymase in chronic hypersensitivity pneumonitis
por: Inoue, Yukihisa, et al.
Publicado: (2020)

Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy
por: Sekine, Akimasa, et al.
Publicado: (2022)

Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
por: Murohashi, Kota, et al.
Publicado: (2020)

Emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Significant accumulation of KRAS mutations in bronchiolar metaplasia-associated honeycomb lesions of interstitial pneumonia
por: Kataoka, Toshiaki, et al.
Publicado: (2022)

Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case–control study
por: Guler, Sabina A., et al.
Publicado: (2021)

Challenges in the Diagnosis and Management of Fibrotic Hypersensitivity Pneumonitis: A Practical Review of Current Approaches
por: Moua, Teng, et al.
Publicado: (2022)

Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis
por: Macaluso, Claudio, et al.
Publicado: (2022)

Fibrotic Hypersensitivity Pneumonitis Diagnosed by a Re-evaluation with Bronchoalveolar Lavage at Disease Deterioration
por: Moda, Mitsuhiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3le760q3bav4ef0mrv0ai0f1l5